Photo: Alexander Koryakov / Kommersant
Clinical human trials of a vaccine against the coronavirus that developed in the center of Virology and biotechnology “Vector”, is scheduled for July 15. This date, RIA Novosti named Director of the Rinat Maksyutov.
According to him, has already selected 300 volunteers. “They fully comply with all the requirements,” — said the Agency interlocutor.
Maksyutov said that in September we will complete the first stage of clinical trials. If they show good results on safety and immunogenicity will begin registration of the drug.
Another Russian vaccine, developed by specialists of the Ministry of defense and the National centre of epidemiology and Microbiology named Gamalei, already being tested on humans. Volunteers noted the normal state of health after the injection, complications arose.
Maksyutov previously reported that three samples of the vaccine in the “Vector” has successfully proved its efficiency and ability to generate immune response.
Video, photo All from Russia.